Does natalizumab improve disease course of secondary progressive multiple sclerosis?
No. Atalizumab treatment for secondary progressive multiple sclerosis did not reduce progression on the primary multicomponent disability endpoint in part 1, but it did reduce progression on its upper-limb component.